Target Name: DPY19L2P2
NCBI ID: G349152
Other Name(s): DPY19L2 pseudogene 2

DPY19L2P2: A Potential Drug Target Or Biomarker

DPY19L2P2, also known as DPY19L2 pseudogene 2, is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its unique genetic variation has led to the development of a wide range of biological phenomena, making it an attractive target for researchers to investigate.

DPY19L2P2 is a gene that encodes a protein known as 2-dimensional protein (2DPro), which is involved in several cellular processes, including cell adhesion, migration, and invasion. It is a member of the TGF-β family, which plays a crucial role in regulating cellular growth, differentiation, and survival.

Studies have shown that genetic variations in the DPY19L2P2 gene have been linked to the development of various diseases. For example, researchers have found that individuals with certain genetic variations, such as those in the DPY19L2P2 gene, are at an increased risk of developing neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

In addition, studies have also shown thatDPY19L2P2 variants are associated with an increased risk of developing certain types of cancer, such as breast, ovarian, and prostate cancer. This suggests that targeting this gene may be an effective way to prevent or treat these cancers.

Another promising aspect of DPY19L2P2 is its potential as a biomarker. The expression of this gene has been shown to be associated with the development of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. This makes it a promising candidate for use as a diagnostic or predictive marker for these conditions.

In conclusion, DPY19L2P2 is a gene that has the potential to be a drug target or biomarker for a wide range of diseases. Its unique genetic variation and involvement in several cellular processes make it an attractive target for researchers to investigate. Further studies are needed to fully understand the role of DPY19L2P2 in disease development and its potential as a diagnostic or predictive marker.

Protein Name: DPY19L2 Pseudogene 2

Functions: Probable C-mannosyltransferase that mediates C-mannosylation of tryptophan residues on target proteins

More Common Targets

DPY19L2P3 | DPY19L2P4 | DPY19L3 | DPY19L3-DT | DPY19L4 | DPY30 | DPYD | DPYD-AS1 | DPYS | DPYSL2 | DPYSL3 | DPYSL4 | DPYSL5 | DQX1 | DR1 | DRAIC | DRAM1 | DRAM2 | DRAP1 | DRAXIN | DRB sensitivity-inducing factor complex | DRC1 | DRC3 | DRC7 | DRD1 | DRD2 | DRD3 | DRD4 | DRD5 | DRD5P1 | DRD5P2 | DRG1 | DRG2 | DRGX | DRICH1 | DROSHA | DRP2 | DSC1 | DSC2 | DSC3 | DSCAM | DSCAM-AS1 | DSCAML1 | DSCC1 | DSCR10 | DSCR4 | DSCR8 | DSCR9 | DSE | DSEL | DSEL-AS1 | DSG1 | DSG1-AS1 | DSG2 | DSG3 | DSG4 | DSN1 | DSP | DSP-AS1 | DSPP | DST | DST-AS1 | DSTN | DSTNP2 | DSTYK | DTD1 | DTD1-AS1 | DTD2 | DTHD1 | DTL | DTNA | DTNB | DTNB-AS1 | DTNBP1 | DTWD1 | DTWD2 | DTX1 | DTX2 | DTX2P1 | DTX2P1-UPK3BP1-PMS2P11 | DTX3 | DTX3L | DTX4 | DTYMK | Dual Specificity Mitogen-Activated Protein Kinase Kinase (MEK) | Dual specificity protein kinase (CLK) | Dual specificity protein tyrosine phosphatase | Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1 | DUBR | DUOX1 | DUOX2 | DUOXA1 | DUOXA2 | DUS1L | DUS2 | DUS3L | DUS4L | DUSP1 | DUSP10 | DUSP11